Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?()()

Mortality associated with cannabis used for treatment of epilepsy is not well documented. We discuss two fatalities in the setting of epilepsy and self-determined therapy with cannabis (SDTC). One patient had probable sudden unexpected death in epilepsy, the second death was due to seizure-associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kollmyer, Devon M., Wright, Kyla E., Warner, Nicole M., Doherty, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348695/
https://www.ncbi.nlm.nih.gov/pubmed/30705819
http://dx.doi.org/10.1016/j.ebcr.2018.11.007
_version_ 1783390147921838080
author Kollmyer, Devon M.
Wright, Kyla E.
Warner, Nicole M.
Doherty, Michael J.
author_facet Kollmyer, Devon M.
Wright, Kyla E.
Warner, Nicole M.
Doherty, Michael J.
author_sort Kollmyer, Devon M.
collection PubMed
description Mortality associated with cannabis used for treatment of epilepsy is not well documented. We discuss two fatalities in the setting of epilepsy and self-determined therapy with cannabis (SDTC). One patient had probable sudden unexpected death in epilepsy, the second death was due to seizure-associated drowning. Both directed SDTC over conventional anti-seizure medications. Where recreational cannabis is legal, decisions to use cannabis are often self-directed and independent of physician advice of cannabis risks, in part because physicians may not be aware of the risk of SDTC. Further study of morbidity and mortality of SDTC in patients with epilepsy is needed.
format Online
Article
Text
id pubmed-6348695
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-63486952019-01-31 Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?()() Kollmyer, Devon M. Wright, Kyla E. Warner, Nicole M. Doherty, Michael J. Epilepsy Behav Case Rep Article Mortality associated with cannabis used for treatment of epilepsy is not well documented. We discuss two fatalities in the setting of epilepsy and self-determined therapy with cannabis (SDTC). One patient had probable sudden unexpected death in epilepsy, the second death was due to seizure-associated drowning. Both directed SDTC over conventional anti-seizure medications. Where recreational cannabis is legal, decisions to use cannabis are often self-directed and independent of physician advice of cannabis risks, in part because physicians may not be aware of the risk of SDTC. Further study of morbidity and mortality of SDTC in patients with epilepsy is needed. Elsevier 2018-12-03 /pmc/articles/PMC6348695/ /pubmed/30705819 http://dx.doi.org/10.1016/j.ebcr.2018.11.007 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Kollmyer, Devon M.
Wright, Kyla E.
Warner, Nicole M.
Doherty, Michael J.
Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?()()
title Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?()()
title_full Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?()()
title_fullStr Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?()()
title_full_unstemmed Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?()()
title_short Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?()()
title_sort are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy?()()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348695/
https://www.ncbi.nlm.nih.gov/pubmed/30705819
http://dx.doi.org/10.1016/j.ebcr.2018.11.007
work_keys_str_mv AT kollmyerdevonm aretheremortalityrisksforpatientswithepilepsywhousecannabistreatmentsasmonotherapy
AT wrightkylae aretheremortalityrisksforpatientswithepilepsywhousecannabistreatmentsasmonotherapy
AT warnernicolem aretheremortalityrisksforpatientswithepilepsywhousecannabistreatmentsasmonotherapy
AT dohertymichaelj aretheremortalityrisksforpatientswithepilepsywhousecannabistreatmentsasmonotherapy

Ejemplares similares